Neurowyzr

Neurowyzr is a healthcare company in Singapore, Singapore, founded in 2019. It has raised $5.2M across 2 rounds, most recently a $2.1M Seed in August 2023.

Healthy Brains, Happier Lives, For Everyone

Headquarters
Singapore
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$5.2M
Last Round
$2.1M SeedAug 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds for this company. The full record is or through the API.

About

Neurowyzr is an ISO 27001:2013 and ISO 13485:2016 certified clinical neuroscience company headquartered in Singapore. Its core product, the Digital Brain Function Screen (DBFS), is a 15–20 minute neuroscience-based cognitive assessment delivered via web browser that evaluates memory, working memory, attention, and executive function. The tool is designed for healthcare providers and pharmaceutical companies to enable early, affordable, and objective detection of brain decline. Neurowyzr's DBFS is registered as a medical device in 9 countries including Singapore (HSA), India (CDSCO), Malaysia (MDA), Indonesia (MOH), Thailand (TFDA), Australia (TGA), Vietnam (DMEC), the UK (MHRA), and the US (FDA). The company was founded in 2019 and has raised funding from Peak XV Partners and Jungle Ventures. Partners include Parkway Shenton, Nutricia (Danone), and Allium Healthcare.

Summary

It lists 11–50 employees. It has raised $5.2M in total across 2 rounds, most recently a $2.1M Seed round in Aug 2023.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundAug 2023
$2.1M

Sign up to see all 2 events

Funding: Seed. Amounts, valuations, and investors where available.

Similar Companies

MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024
Inizio

Inizio helps health and life sciences clients realize product potential through deep expertise, g...

New York, United States10001+Healthcare
Venture RoundTotal funding$4.4B

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Neurowyzr on Indexed.vc
<a href="https://indexed.vc/companies/neurowyzr"><img src="https://indexed.vc/api/badge/company/neurowyzr" alt="Neurowyzr on Indexed.vc" width="260" height="76" /></a>